Astrazeneca settlement seroquel
AstraZeneca will pay $ million to settle two lawsuits brought against it its cholesterol drug Crestor and its antipsychotic Seroquel off label. Firm denies allegations that it actively marketed the antipsychotic for off-label indications. AstraZeneca is still denying allegations that it actively. AstraZeneca Plc agreed to pay $ million to settle a Texas claim alleging Texas said drugmaker pushed Seroquel for unapproved uses.